[1] |
WANG Zifei, DING Yahui, LI Yan, LUAN Xin, TANG Min.
Application of 3D bioprinting in cancer research and tissue engineering
[J]. China Oncology, 2024, 34(9): 814-826.
|
[2] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[3] |
WANG Manli, CHEN Hui, DUAN Zhi, XU Qimei, LI Zhen.
A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis
[J]. China Oncology, 2024, 34(7): 628-638.
|
[4] |
LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan.
Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(7): 669-679.
|
[5] |
TANG Nan, HUANG Huixia, LIU Xiaojian.
Integrated single-cell sequencing and transcriptome sequencing to reveal a 9-gene prognostic signature of immune cells in colorectal cancer
[J]. China Oncology, 2024, 34(6): 548-560.
|
[6] |
WANG Xiaocong, LI Ming.
The value of single-cell sequencing in oral squamous cell carcinoma research
[J]. China Oncology, 2024, 34(5): 501-508.
|
[7] |
LIN Yicong, WANG Yue, XUE Qianqian, ZHENG Qiang, JIN Yan, HUANG Ziling, LI Yuan.
Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications
[J]. China Oncology, 2024, 34(4): 368-379.
|
[8] |
LI Xinran, LIANG Yiyi, TU Hong.
Research progress of the intratumoral microbiome
[J]. China Oncology, 2023, 33(9): 866-873.
|
[9] |
ZHANG Shaoqiu, YAN Li, LI Ruichen, ZHAO Yang, WANG Xiaoshen, YANG Xuguang, ZHU Yi.
Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma
[J]. China Oncology, 2023, 33(6): 629-636.
|
[10] |
CHEN Lijun, WANG Yichen, ZHENG Qiang, WANG Yue, JIN Yan, LI Yuan.
Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma
[J]. China Oncology, 2023, 33(5): 469-477.
|
[11] |
YANG Wenxiao, GUO Linwei, LING Hong, HU Xin.
Characterization of immune microenvironment identifies prognostic and immunotherapy benefit for trastuzumab-based therapy
[J]. China Oncology, 2023, 33(5): 484-498.
|
[12] |
LU Yu, XI Yumeng, HE Xiaoming, YANG Shaokun, ZHANG Jia, WANG Lei, HE Chaoxing, XIANG Bai.
Advances in the application of co-culture strategies in organoids
[J]. China Oncology, 2023, 33(3): 293-302.
|
[13] |
YANG Wenbo, ZHANG Bin, WU Jiahui, CUI Jie.
Current status and treatment direction of the immune microenvironment of castration-resistant prostate cancer
[J]. China Oncology, 2023, 33(10): 945-953.
|
[14] |
XUE Ying, MAO Yunyu, XU Jianqing.
Progress in construction of hypoxia-sensitive CAR-T cell for solid tumor therapy
[J]. China Oncology, 2023, 33(1): 71-77.
|
[15] |
JIANG Jinling, ZHOU Chenfei, XI Wenqi, SHI Min, GEN Mei, ZHAO Liqin, CAI Qu, JIANG Jinsong, ZHANG Jun.
Optimization of 5-FU metronomic chemotherapy strategy and regulation of the immune microenvironment in gastric cancer: an in vivo study
[J]. China Oncology, 2022, 32(7): 596-605.
|